Clinical Trial Update: Goserelin for Ovarian Protection in Premenopausal Patients Receiving Cyclophosphamide [Phase 2]

View source ↗

Summary

This entry summarizes a Phase 2 trial evaluating goserelin for protecting ovarian function in premenopausal patients receiving cyclophosphamide; current status …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Premature Ovarian Insufficiency

Drugs mentioned

• Zoladex (goserelin)

Snippet

Sponsor: Assiut University | Conditions: Ovarian Failure | Phase 2 | Status: UNKNOWN